Launch of Galenica Diagnostics: Acquisition of labor team completed
- labor team will become part of the Galenica network once the acquisition is complete.
- The fourth-largest private laboratory in Switzerland will continue to operate under the labor team brand as part of the new Galenica Diagnostics business unit.
- The Board of Directors is made up of members of Galenica and laboratory experts.
Galenica has successfully completed the acquisition of Diagnostics Group GmbH (Labor Team Group including labor team w ag), one of Switzerland’s leading diagnostic service providers. The transaction was completed on 9 September 2025 with the approval of the Federal Competition Commission (COMCO) around two months after the acquisition was announced. By purchasing labor team, Galenica is entering the diagnostics business.
Management and laboratory expertise on the Board of Directors
In future, labor team will be managed as an independent «Galenica Diagnostics» business unit in the Products & Care segment. The company will continue to operate on the market as a legally independent entity and brand. The new Board of Directors of labor team w ag brings together the management experience of the Galenica Group and specialist laboratory expertise. The current chairman of the board of directors, Ole Wiesinger, will continue to ensure stability in this role. Thomas Szuran, Chief Products & Home Care at Galenica, Julian Fiessinger, CFO of Galenica as well as Christian Rebhan, CEO Tentamus Group, and Ralph Panoff (current) are valuable additions to the board. Rahel Kubik, who has been a member of the Board of Directors to date, will be stepping down from the Board. labor team and Galenica would like to thank her for her dedication over the past years. The current management team of labor team headed by CEO Alain M. Cahen will maintain operational responsibility.
Expanding the healthcare network
In acquiring labor team, Galenica is adding a leading diagnostic service provider with a strong market position to its healthcare network. In addition to the existing offerings in the area of drugs and products for the physician market, it will also be possible to offer innovative laboratory services as a single provider.
In the long term, Galenica is planning to develop an innovative range of selected diagnostic laboratory services within the scope of the regulatory possibilities in pharmacies. This will further strengthen healthcare provision in Switzerland.
